Skip to content
Clinical Trial Events
SCOPE Summit for Clinical Ops Executives

Talk Feasibility & Study Start-Up · Site Engagement & Enablement

Feasibility Process Update to Ensure Active Site Engagement: One Year Later

Thu, Feb 6, 2025 · 10:10–10:40 AM EST Rosen Shingle Creek

About this session

A year has passed since AstraZeneca implemented enhancements to our feasibility process, aimed at fostering active engagement from the initial interaction through to site selection. Over the past year, we've had the opportunity to test these improvements, gather insights, and refine our approach. In this session, we will share the valuable learnings from this journey, discuss the additional updates we've made, and outline our future plans to further optimize the process.

Speaker

  • Katie Bonner

    Director Strategic Feasibility and Analytics · AstraZeneca

    Speaker